While GNBT has failed to provide any morsel of positive real progress, the critical investors of the company on these Boards have in spite of the deteriorating situation, remain rational, tolerant and constructive. This must be putting adding burden on the corporate governance, i.e. Joe, who would find it much easier to dismiss and blame in responding to an expected mob of angry ranting lunatics with opposing remarks. Congratulations to the reserved GNBT longs.
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links